Mobile Breathalyzers In Substance Use Disorder Treatment: Utilization, Validity, And Utility In Treatment Provision | 30483
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2384

Journal of Addiction Research & Therapy received 2384 citations as per google scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Mobile breathalyzers in substance use disorder treatment: Utilization, validity, and utility in treatment provision

4th International Conference and Exhibition on Addiction Research & Therapy

Adi Jaffe

ScientificTracks Abstracts: J Addict Res Ther

DOI: 10.4172/2155-6105.S1.021

Aims: To describe the feasibility, implementation, validity and utilization of mobile momentary-assessment breathalyzers within the context of an Intensive Outpatient (IOP) treatment for Alcohol Use Disorder (AUD). Methods: Fifty-five participants in an IOP treatment program in Southern California were provided breathalyzers at the onset of treatment. Breathalyzer assessment schedules were set based on client’s self-report of sleep schedule and three to five assessments (M=4) per day were conducted remotely. Breathalyzer data was recorded for the duration of treatment, which lasted between twoto- six months (M=3.5 months). Participants were given a short survey to assess their satisfaction with the breathalyzer system. Data preparation and analysis was conducted using SPSS. Results: Analysis indicated substantial presence of missing data when looking at individual data points. Analysis of relative missing frequency, relative non-zero BAC readings as well as maximum BAC were conducted for the overall sample and based on initial treatment-goal selection. Conclusions: Our study reveals that the utilization of momentary substance detection methods, such as a breathalyzer, within an IOP treatment context is feasible. Furthermore, the study reveals specific analysis recommendations for providers engaged in such data collection. Finally the use of reporting adherence as a measure of treatment progress is suggested given the relationship between treatment success and breathalyzer reporting observance.

Adi Jaffe received his PhD from the University of California, Los Angeles (UCLA) in 2010. Even before he graduated, his name had become known through his online and academic writing. His views on addiction and his research on the topic have been published in dozens of journals and online publications and he has appeared on several television shows and documentaries discussing current topics in addiction and the problem of addiction as a whole. He also teaches courses at UCLA and the California State University in Long Beach that address addiction specifically or biological psychology and behavioral neuroscience more generally. His view is a holistic one, drawing from the best and most recent research to bring as a complete solution to addiction clients. At Alternatives Behavioral Health, LLC, USA, he serves as the Director of Research, education, and innovation and is in charge of client monitoring, technology solutions, and data collections and outcomes research. His goal is to make Alternatives the best treatment program.